Lindsay Surgical Supplies Limited 04392834 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is supply of surgical instruments Digita Accounts Production Advanced 6.30.9574.0 true true 04392834 2023-04-01 2024-03-31 04392834 2024-03-31 04392834 bus:OrdinaryShareClass1 2024-03-31 04392834 bus:OrdinaryShareClass2 2024-03-31 04392834 core:CurrentFinancialInstruments 2024-03-31 04392834 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04392834 core:FurnitureFittingsToolsEquipment 2024-03-31 04392834 core:MotorVehicles 2024-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-03-31 04392834 bus:SmallEntities 2023-04-01 2024-03-31 04392834 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 04392834 bus:FilletedAccounts 2023-04-01 2024-03-31 04392834 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 04392834 bus:RegisteredOffice 2023-04-01 2024-03-31 04392834 bus:CompanySecretary1 2023-04-01 2024-03-31 04392834 bus:Director1 2023-04-01 2024-03-31 04392834 bus:Director2 2023-04-01 2024-03-31 04392834 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 04392834 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 04392834 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 04392834 bus:Agent1 2023-04-01 2024-03-31 04392834 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 04392834 core:MotorVehicles 2023-04-01 2024-03-31 04392834 core:OfficeEquipment 2023-04-01 2024-03-31 04392834 core:KeyManagementPersonnel 2023-04-01 2024-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-04-01 2024-03-31 04392834 countries:EnglandWales 2023-04-01 2024-03-31 04392834 2023-03-31 04392834 core:FurnitureFittingsToolsEquipment 2023-03-31 04392834 core:MotorVehicles 2023-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-03-31 04392834 2022-04-01 2023-03-31 04392834 2023-03-31 04392834 bus:OrdinaryShareClass1 2023-03-31 04392834 bus:OrdinaryShareClass2 2023-03-31 04392834 core:CurrentFinancialInstruments 2023-03-31 04392834 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 04392834 core:FurnitureFittingsToolsEquipment 2023-03-31 04392834 core:MotorVehicles 2023-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-04-01 2023-03-31 04392834 2022-03-31 04392834 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04392834

Lindsay Surgical Supplies Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

image-name
 

Lindsay Surgical Supplies Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Lindsay Surgical Supplies Limited

Company Information

Directors

Mr Robert Lindsay

Mr Andrew Lindsay

Company secretary

Mrs Andrea Janine Marie Lindsay

Registered office

92-94 Castle Lane West
Bournemouth
Dorset
BH9 3JU

Bankers

HSBC Bank plc
WESTBOURNE
111 Poole Road
Westbourne
Bournemouth
Dorset
BH4 9BQ

Accountants

A Ferguson Associates Ltd
Accountancy and Taxation Services
Alum House
5 Alum Chine Road
Bournemouth
Dorset
BH4 8DT

 

Lindsay Surgical Supplies Limited

(Registration number: 04392834)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

13,836

16,641

Current assets

 

Stocks

5

67,911

79,298

Debtors

6

106,431

114,549

Cash at bank and in hand

 

118,721

120,706

 

293,063

314,553

Creditors: Amounts falling due within one year

7

(95,834)

(95,098)

Net current assets

 

197,229

219,455

Total assets less current liabilities

 

211,065

236,096

Provisions for liabilities

(634)

(937)

Net assets

 

210,431

235,159

Capital and reserves

 

Called up share capital

8

4

4

Retained earnings

210,427

235,155

Shareholders' funds

 

210,431

235,159

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 16 August 2024 and signed on its behalf by:
 

 

Lindsay Surgical Supplies Limited

(Registration number: 04392834)
Balance Sheet as at 31 March 2024

.........................................
Mr Robert Lindsay
Director

.........................................
Mr Andrew Lindsay
Director

 
     
 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
92-94 Castle Lane West
Bournemouth
Dorset
BH9 3JU
England

These financial statements were authorised for issue by the Board on 16 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% reducing balance

Furniture, fixtures and fittings

15% reducing balance

Motor vehicles

25% reducing balance

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2023 - 6).

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2023

30,948

13,250

44,198

Additions

1,631

-

1,631

At 31 March 2024

32,579

13,250

45,829

Depreciation

At 1 April 2023

24,037

3,520

27,557

Charge for the year

2,004

2,432

4,436

At 31 March 2024

26,041

5,952

31,993

Carrying amount

At 31 March 2024

6,538

7,298

13,836

At 31 March 2023

6,911

9,730

16,641

5

Stocks

2024
£

2023
£

Other inventories

67,911

79,298

6

Debtors

Current

2024
£

2023
£

Trade debtors

72,909

77,507

Prepayments

4,247

5,767

Other debtors

29,275

31,275

 

106,431

114,549

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

7

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

50,312

52,334

Taxation and social security

43,004

40,331

Accruals and deferred income

2,518

2,433

95,834

95,098

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary A of £0.01 each

200

2

200

2

Ordinary B of £0.01 each

200

2

200

2

400

4

400

4

9

Related party transactions

Loans to related parties

2024

Key management
£

Total
£

At start of period

28,900

28,900

Advanced

90,000

90,000

Repaid

(92,000)

(92,000)

At end of period

26,900

26,900

2023

Key management
£

Total
£

At start of period

38,400

38,400

Advanced

82,500

82,500

Repaid

(92,000)

(92,000)

At end of period

28,900

28,900

 

Lindsay Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Terms of loans to related parties

Interest free loans to directors.
The terms of the loan make provision for any loans to the directors to be repaid back to the company on demand at very short notice.